SMOOTH MUSCLE CELL NEOPLASM

SMOOTH MUSCLE CELL NEOPLASM was reported 418 times

SMOOTH MUSCLE CELL NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 136 0.0061
1 Nucleoside Analog Antiviral [EPC] 108 0.0013
2 Human Immunoglobulin G [EPC] 26 0.0012
3 Calcineurin Inhibitor Immunosuppressant [EPC] 107 0.0008
4 Antimetabolite Immunosuppressant [EPC] 15 0.0007
5 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 69 0.0006
6 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 58 0.0005
7 CD52-directed Cytolytic Antibody [EPC] 9 0.0005
8 CD20-directed Cytolytic Antibody [EPC] 100 0.0003
9 Alkylating Drug [EPC] 72 0.0003
10 Histone Deacetylase Inhibitor [EPC] 1 0.0003
11 Corticosteroid [EPC] 329 0.0003
12 Kinase Inhibitor [EPC] 104 0.0002
13 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
14 Purine Antimetabolite [EPC] 12 0.0001
15 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0001
16 Central alpha-2 Adrenergic Agonist [EPC] 3 0.0001
17 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 5 0.0001
18 Azole Antifungal [EPC] 8 0.0001
19 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0000
20 BCL-2 Inhibitor [EPC] 1 0.0000
21 Platinum-based Drug [EPC] 2 0.0000
22 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
23 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
24 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
25 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
26 Osmotic Laxative [EPC] 1 0.0000
27 Insulin Analog [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 1 0.0000
29 Tumor Necrosis Factor Blocker [EPC] 1 0.0000